Platelets Are at the Nexus of Vascular Diseases

Héloïse Lebas1, Katia Yahiaoui1, Raphaël Martos1

  • 1Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Sorbonne Paris Cite, Univ Paris Diderot, Paris, France.

Insights

Platelets play a key role in cardiovascular diseases (CVD). Understanding platelet functions beyond clotting is crucial for developing safer treatments for vascular and thrombo-inflammatory diseases.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Immunology

Background:

  • Platelets are critical in cardiovascular diseases (CVD).
  • Current antiplatelet therapies face challenges with bleeding complications.
  • Platelet interactions extend beyond hemostasis to inflammation and vascular injury.

Purpose of the Study:

  • To provide a comprehensive overview of platelet mechanisms in vascular diseases.
  • To explore the role of platelet functions in CVD progression.
  • To identify new therapeutic strategies for thrombo-inflammatory diseases.

Main Methods:

  • Literature review of recent studies on platelet function in vascular diseases.
  • Analysis of platelet interactions with vascular cells and leukocytes.
  • Synthesis of current knowledge on platelet mechanisms in thrombo-inflammation.

Main Results:

  • Platelets are implicated in CVD progression through various mechanisms beyond aggregation.
  • Platelet interactions with other cells contribute to vascular injury and inflammation.
  • Existing antiplatelet drugs have limitations regarding bleeding risks.

Conclusions:

  • A deeper understanding of platelet biology is essential for advancing CVD treatment.
  • Targeting novel platelet pathways may offer safer therapeutic options.
  • Further research into platelet mechanisms is needed for effective management of vascular and thrombo-inflammatory conditions.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.5K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
12.9K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K